OSR Holdings, Inc.(OSRH)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-02-16 | Bellevue Global Life Science Investors LLC 10% Owner | Purchase | +430,000 | +100.00%430,000 | $10.00 | $4,300,000 | View SEC filing | |
| 2023-02-16 | Hwang Kuk Hyoun Chief Executive Officer | Purchase | +430,000 | +100.00%430,000 | $10.00 | $4,300,000 | View SEC filing |
1-2 of 2